{"gao_id": "GAO-18-336T", "published": "2018-01-17T12:00:00Z", "released": "2018-01-17T07:00:00Z", "summary": "What can Medicare do to help address the nation's opioid crisis? We've previously found problems such as \"doctor shopping\" and questionable prescribing practices in Medicare's prescription drug benefits. With 14.4 million people receiving at least one opioid prescription through Medicare in 2016, reducing opioid overprescribing could make a difference. We looked at Medicare's efforts to reduce inappropriate opioid prescribing, and we revisit our analysis in...", "title": "Prescription Opioids: Medicare Should Expand Oversight Efforts to Reduce the Risk of Harm", "topics": ["Prescription drugs", "Pharmaceutical industry", "Health Care", "Medicare", "Controlled substances", "Substance abuse", "Beneficiaries", "Data collection", "Monitoring", "Drugs", "Reporting requirements", "Internal controls"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-18-336t", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-18-336t-highlights.pdf"}, {"title": "Full Report (15 pages)", "url": "https://www.gao.gov/assets/gao-18-336t.pdf"}, {"title": "Accessible PDF (16 pages)", "url": "https://www.gao.gov/assets/690/689468.pdf"}]}